Zacks Research Upgrades Astera Labs (NASDAQ:ALAB) to “Strong-Buy”

Astera Labs (NASDAQ:ALABGet Free Report) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Tuesday,Zacks.com reports.

Several other equities research analysts have also commented on ALAB. Morgan Stanley upped their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Citigroup reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Bank of America raised their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Evercore reaffirmed an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $325.25.

Get Our Latest Research Report on Astera Labs

Astera Labs Trading Up 2.2%

Shares of NASDAQ:ALAB opened at $318.80 on Tuesday. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market cap of $55.31 billion, a PE ratio of 157.82 and a beta of 3.84. The company’s 50 day moving average is $358.62 and its 200 day moving average is $238.55.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts predict that Astera Labs will post 2.7 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other news, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the completion of the sale, the director owned 5,550 shares of the company’s stock, valued at $2,192,472. This represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the completion of the sale, the director owned 53,961 shares of the company’s stock, valued at $16,826,658.63. This trade represents a 6.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,256,894 shares of company stock valued at $362,763,135 in the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ALAB. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Astera Labs in the second quarter valued at approximately $77,980,000. Meiji Yasuda Asset Management Co Ltd. acquired a new stake in shares of Astera Labs in the 2nd quarter worth $254,000. Matters Capital LLC acquired a new stake in shares of Astera Labs in the 2nd quarter worth $241,000. Bank of Nova Scotia purchased a new position in shares of Astera Labs during the 2nd quarter worth $50,760,000. Finally, Kirtland Hills Capital Management LLC purchased a new position in shares of Astera Labs during the 2nd quarter worth $637,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Brokerages assign ALAB a consensus “Moderate Buy” rating, indicating generally favorable views among covering analysts. Astera Labs Given Consensus Recommendation of Moderate Buy
  • Positive Sentiment: Northland Securities substantially raised its earnings forecasts, including FY2026 EPS to $2.75 from $1.82 and FY2027 EPS to $5.43 from $2.26. The revisions reflect expectations for strong growth in Astera’s AI connectivity business. Northland Securities Earnings Estimate Revisions
  • Positive Sentiment: Analyst commentary highlights record growth, rising PCIe 6 demand and an expanding connectivity portfolio, potentially helping Astera compete with Marvell and Credo. ALAB Benefits From PCIe Demand
  • Positive Sentiment: A bullish Seeking Alpha analysis sees Astera’s shift toward integrated, rack-level connectivity as an inflection point. Its Scorpio high-radix fabric switch could become the company’s largest revenue source, increase average selling prices and support cross-selling. The article assigns a Buy rating and a $370 price target. Astera Labs AI Fabric Inflection
  • Positive Sentiment: AMD’s planned Helios rack-scale AI systems could benefit Astera as an ecosystem supplier, adding another potential demand driver beyond direct accelerator vendors. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
  • Neutral Sentiment: Despite raising its earnings estimates, Northland Securities maintained a “Market Perform” rating, signaling that strong growth expectations may already be reflected in ALAB’s valuation.
  • Negative Sentiment: Astera Labs trades at a very high valuation, with a reported P/E ratio near 158 and a beta of 3.84. This leaves the stock particularly sensitive to profit-taking, changes in AI spending expectations and broader technology-sector weakness.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.